Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Get quick answers to your questions about the article from our AI researcher chatbot

Primary Location

Authors

Topics

Keywords

Related Works

Title: $Risk Factors for Patients With Pelvic Lymph Node Metastases Following Radical Cystectomy With En Bloc Pelvic Lymphadenectomy: The Concept of Lymph Node Density
Abstract: No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Jul 2003Risk Factors for Patients With Pelvic Lymph Node Metastases Following Radical Cystectomy With En Bloc Pelvic Lymphadenectomy: The Concept of Lymph Node Density JOHN P. STEIN, JIE CAI, SUSAN GROSHEN, and DONALD G. SKINNER JOHN P. STEINJOHN P. STEIN More articles by this author , JIE CAIJIE CAI More articles by this author , SUSAN GROSHENSUSAN GROSHEN More articles by this author , and DONALD G. SKINNERDONALD G. SKINNER More articles by this author View All Author Informationhttps://doi.org/10.1097/01.ju.0000072422.69286.0eAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We evaluated the clinical outcomes and risk factors for progression in a large cohort of patients with lymph node metastases following en bloc radical cystectomy and bilateral pelvic lymphadenectomy. Materials and Methods: From July 1971 through December 1997, 1,054 patients underwent radical cystectomy and bilateral pelvic-iliac lymphadenectomy for high grade, invasive transitional cell carcinoma of the bladder. Of these patients 244 (23%) with a median age of 66 years (range 36 to 90) had pathological lymph node metastases. Overall 139 of the 244 patients (57%) received some form of chemotherapy. At a median followup of greater than 10 years (range 0 to 28) outcomes data were analyzed in univariate analysis according to tumor grade, carcinoma in situ, primary bladder tumor stage, pathological subgroups, total number of lymph nodes removed and involved with tumor, and lymph node density (total number of positive lymph nodes/total number removed). In addition, the form of urinary diversion and the administration of chemotherapy were also evaluated. Multivariate analysis was then performed to analyze these variables independently. Results: The incidence of positive lymph nodes increased with higher p stage and pathological subgroups. Of 669 patients 75 (11%) with organ confined primary tumors and 169 of 385 (44%) with extravesical tumor extension had involved lymph nodes. The median number of lymph nodes removed in the 244 lymph node positive cases was 30 (range 1 to 96), while the median number of positive lymph nodes was 2 (range 1 to 63). Overall recurrence-free survival at 5 and 10 years for the 244 patients with lymph node positive disease was 35% and 34%, respectively. Patients with lymph node positive disease and an organ confined primary bladder tumor had significantly improved 10-year recurrence-free survival compared with those with extravesical tumor extension (44% vs 30%, p = 0.003). The total number of lymph nodes removed at surgery was also prognostic. Patients with 15 or less lymph nodes removed had 25% 10-year recurrence-free survival compared with 36% when greater than 15 lymph nodes were removed. Recurrence-free survival at 10 years for patients with 8 or less positive lymph nodes was significantly higher than in those with greater than 8 positive lymph nodes (40% vs 10%, p <0.001). The novel concept of lymph node density was also a significant prognostic factor. Patients with a lymph node density of 20% or less had 43% 10-year recurrence-free survival compared with only 17% survival at 10 years when lymph node density was greater than 20% (p <0.001). On multivariate analysis the total number of lymph nodes involved, pathological subgroups of the primary bladder tumor, lymph node density and adjuvant chemotherapy remained significant and independent risk factors for recurrence-free and overall survival. Conclusions: Patients with lymph node tumor involvement following radical cystectomy may be stratified into high risk groups based on the primary bladder tumor, pathological subgroup, number of lymph nodes removed and total number of lymph nodes involved. Lymph node density, which is a novel prognostic indicator, may better stratify lymph node positive cases because this concept collectively accounts for the total number of positive lymph nodes (tumor burden) and the total number of lymph nodes removed (extent of lymphadenectomy). Future staging systems and the application of adjuvant therapies in clinical trials should consider applying lymph node density to help standardize this high risk group of patients following radical cystectomy. References 1 : Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol2001; 19: 666. Google Scholar 2 : Cystectomy for bladder cancer: a contemporary series. J Urol2001; 165: 1111. Link, Google Scholar 3 : The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol1993; 149: 758. Link, Google Scholar 4 : Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol1982; 128: 34. Link, Google Scholar 5 : Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol2002; 167: 1295. Link, Google Scholar 6 : Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int2000; 85: 817. Google Scholar 7 : Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol1998; 160: 2015. Link, Google Scholar 8 : Radical cystectomy and pelvic lymphadenectomy in the treatment of infiltrative bladder cancer. In: Bladder Cancer: Current Diagnosis and Treatment. Edited by . Totowa, New Jersey: Humana Press, Inc.2001: 267. Google Scholar 9 : Classification of bladder tumours based on the cellular pattern. Acta Chir Scand1965; 130: 371. Google Scholar 10 AJCC Cancer Staging Manual. Edited by . Philadelphia: Lippincott-Raven1997: 241. Google Scholar 11 : Nonparametric estimation from incomplete observations. J Amer Stat Ass1958; 53: 457. Google Scholar 12 : Survival Analysis. New York: John Wiley1981: 114. Google Scholar 13 : Comparison of Survival Curves. Oxford, United Kingdom: Oxford University Press1988: 398. Google Scholar 14 : Chi-square tests with n degree of freedom: extensions of the Mantel Haenszel procedure. J Am Stat Assoc1963; 58: 690. Google Scholar 15 : Maximally selected chi square statistics. Biometrics1982; 38: 1011. Google Scholar 16 : Maximally selected chi square statistics for small samples. Biometrics1982; 38: 1017. Google Scholar 17 : Regression models and life-tables. J Roy Stat Soc1972; 34: 187. Google Scholar 18 : Indications for early cystectomy. Semin Urol Oncol2000; 18: 289. Google Scholar 19 : Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol2001; 166: 19. Link, Google Scholar 20 : Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol1999; 161: 449. Link, Google Scholar From the Departments of Urology and Preventive Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California© 2003 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byChang S (2018) Re: Occult Metastases in Pelvic Lymphadenectomy Specimens from Patients with Urothelial Carcinoma of the BladderJournal of Urology, VOL. 197, NO. 5, (1218-1219), Online publication date: 1-May-2017.Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Ibuki N, Uehara H, Komura K, Minami K, Uchimoto T, Saito K, Takai T, Tanda N, Yamamoto K, Narumi Y and Kiyama S (2018) Novel Bladder Preservation Therapy with Osaka Medical College RegimenJournal of Urology, VOL. 193, NO. 2, (443-450), Online publication date: 1-Feb-2015.Fajkovic H, Cha E, Jeldres C, Donner G, Chromecki T, Margulis V, Novara G, Lotan Y, Raman J, Kassouf W, Seitz C, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Breinl E, Pycha A, Ficarra V, Montorsi F, Karakiewicz P, Scherr D and Shariat S (2018) Prognostic Value of Extranodal Extension and Other Lymph Node Parameters in Patients With Upper Tract Urothelial CarcinomaJournal of Urology, VOL. 187, NO. 3, (845-851), Online publication date: 1-Mar-2012.Abaza R, Dangle P, Gong M, Bahnson R and Pohar K (2018) Quality of Lymphadenectomy is Equivalent With Robotic and Open Cystectomy Using an Extended TemplateJournal of Urology, VOL. 187, NO. 4, (1200-1205), Online publication date: 1-Apr-2012.Davis J, Gaston K, Anderson R, Dinney C, Grossman H, Munsell M and Kamat A (2018) Robot Assisted Extended Pelvic Lymphadenectomy at Radical Cystectomy: Lymph Node Yield Compared With Second Look Open DissectionJournal of Urology, VOL. 185, NO. 1, (79-84), Online publication date: 1-Jan-2011.Jeong I, You D, Kim J, Song C, Hong J, Ahn H and Kim C (2018) Outcomes of Single Lymph Node Positive Urothelial Carcinoma After Radical CystectomyJournal of Urology, VOL. 185, NO. 6, (2085-2090), Online publication date: 1-Jun-2011.Dangle P, Gong M, Bahnson R and Pohar K (2018) How Do Commonly Performed Lymphadenectomy Templates Influence Bladder Cancer Nodal Stage?Journal of Urology, VOL. 183, NO. 2, (499-504), Online publication date: 1-Feb-2010.Stein J, Penson D, Lee C, Cai J, Miranda G and Skinner D (2018) Long-Term Oncological Outcomes in Women Undergoing Radical Cystectomy and Orthotopic Diversion for Bladder CancerJournal of Urology, VOL. 181, NO. 5, (2052-2059), Online publication date: 1-May-2009.Hellenthal N, Ramírez M, Evans C, deVere White R and Koppie T (2018) Trends in Pelvic Lymphadenectomy at the Time of Radical Cystectomy: 1988 to 2004Journal of Urology, VOL. 181, NO. 6, (2490-2495), Online publication date: 1-Jun-2009.Svatek R, Munsell M, Kincaid J, Hegarty P, Slaton J, Busby J, Gaston K, Spiess P, Pagliaro L, Tamboli P and Pettaway C (2018) Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile CancerJournal of Urology, VOL. 182, NO. 6, (2721-2727), Online publication date: 1-Dec-2009.Stein J, Penson D, Cai J, Miranda G, Skinner E, Dunn M, Groshen S, Lieskovsky G and Skinner D (2018) Radical Cystectomy With Extended Lymphadenectomy: Evaluating Separate Package Versus en Bloc Submission for Node Positive Bladder CancerJournal of Urology, VOL. 177, NO. 3, (876-882), Online publication date: 1-Mar-2007.Herr H (2018) The Concept of Lymph Node Density—Is it Ready for Clinical Practice?Journal of Urology, VOL. 177, NO. 4, (1273-1276), Online publication date: 1-Apr-2007.Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H and Tanabe K (2018) Impact of the Extent of Regional Lymphadenectomy on the Survival of Patients With Urothelial Carcinoma of the Upper Urinary TractJournal of Urology, VOL. 178, NO. 4, (1212-1217), Online publication date: 1-Oct-2007.Steven K and Poulsen A (2018) Radical Cystectomy and Extended Pelvic Lymphadenectomy: Survival of Patients With Lymph Node Metastasis Above the Bifurcation of the Common Iliac Vessels Treated With Surgery OnlyJournal of Urology, VOL. 178, NO. 4, (1218-1224), Online publication date: 1-Oct-2007.Kassouf W, Leibovici D, Munsell M, Dinney C, Grossman H and Kamat A (2018) Evaluation of the Relevance of Lymph Node Density in a Contemporary Series of Patients Undergoing Radical CystectomyJournal of Urology, VOL. 176, NO. 1, (53-57), Online publication date: 1-Jul-2006.BECK S, FOSTER R, BIHRLE R, CHENG L, ULBRIGHT T and DONOHUE J (2018) IMPACT OF THE NUMBER OF POSITIVE LYMPH NODES ON DISEASE-FREE SURVIVAL IN PATIENTS WITH PATHOLOGICAL STAGE B1 NONSEMINOMATOUS GERM CELL TUMORJournal of Urology, VOL. 174, NO. 1, (143-145), Online publication date: 1-Jul-2005.SOLSONA E, IBORRA I, DUMONT R, RUBIO J, CASANOVA J and ALMENAR S (2018) RISK GROUPS IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: STATISTICAL AND CLINICAL MODEL IMPROVING HOMOGENEITYJournal of Urology, VOL. 174, NO. 4 Part 1, (1226-1230), Online publication date: 1-Oct-2005.DANESHMAND S, STEIN J, LESSER T, QUEK M, NICHOLS P, MIRANDA G, CAI J, GROSHEN S, SKINNER E and SKINNER D (2018) PROGNOSIS OF SEMINAL VESICLE INVOLVEMENT BY TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, VOL. 172, NO. 1, (81-84), Online publication date: 1-Jul-2004.ABDEL-LATIF M, ABOL-ENEIN H, EL-BAZ M and GHONEIM M (2018) NODAL INVOLVEMENT IN BLADDER CANCER CASES TREATED WITH RADICAL CYSTECTOMY: INCIDENCE AND PROGNOSISJournal of Urology, VOL. 172, NO. 1, (85-89), Online publication date: 1-Jul-2004.BOCHNER B, CHO D, HERR H, DONAT M, KATTAN M and DALBAGNI G (2018) PROSPECTIVELY PACKAGED LYMPH NODE DISSECTIONS WITH RADICAL CYSTECTOMY: EVALUATION OF NODE COUNT VARIABILITY AND NODE MAPPINGJournal of Urology, VOL. 172, NO. 4 Part 1, (1286-1290), Online publication date: 1-Oct-2004.ABOL-ENEIN H, EL-BAZ M, ABD EL-HAMEED M, ABDEL-LATIF M and GHONEIM M (2018) LYMPH NODE INVOLVEMENT IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A PATHO-ANATOMICAL STUDY—A SINGLE CENTER EXPERIENCEJournal of Urology, VOL. 172, NO. 5, (1818-1821), Online publication date: 1-Nov-2004.FINELLI A, GILL I, DESAI M, MOINZADEH A, MAGI-GALLUZZI C and KAOUK J (2018) LAPAROSCOPIC EXTENDED PELVIC LYMPHADENECTOMY FOR BLADDER CANCER: TECHNIQUE AND INITIAL OUTCOMESJournal of Urology, VOL. 172, NO. 5, (1809-1812), Online publication date: 1-Nov-2004. Volume 170Issue 1July 2003Page: 35-41 Advertisement Copyright & Permissions© 2003 by American Urological Association, Inc.Keywordscystectomybladderriskcarcinoma, transitional celllymph nodesMetricsAuthor Information JOHN P. STEIN More articles by this author JIE CAI More articles by this author SUSAN GROSHEN More articles by this author DONALD G. SKINNER More articles by this author Expand All Advertisement PDF downloadLoading ...